Royal Biologics Announces the Launch of Cryo-Cord™, the First Non-DMSO Viable Umbilical Cord Graft

Royal Biologics Announces the Launch of Cryo-Cord™, the First Non-DMSO Viable Umbilical Cord Graft

Cryo-Cord™offers a new enhancement to traditional wound care therapies and is the first DMSO-free cryoprotectant graft on the market. Cryo-Cord™ is intended for use as a soft tissue barrier or wound dressing. Available from Royal Biologics, it is processed using aseptic techniques and frozen with a proprietary cryoprotectant.

Format

JPEG

Source

Royal Biologics

Downloads